Teleflex Inc
NYSE:TFX

Watchlist Manager
Teleflex Inc Logo
Teleflex Inc
NYSE:TFX
Watchlist
Price: 136.56 USD -0.07% Market Closed
Market Cap: $6B

Teleflex Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Teleflex Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Teleflex Inc
NYSE:TFX
Free Cash Flow
$245.4m
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
0%
Boston Scientific Corp
NYSE:BSX
Free Cash Flow
$3.7B
CAGR 3-Years
57%
CAGR 5-Years
30%
CAGR 10-Years
35%
Edwards Lifesciences Corp
NYSE:EW
Free Cash Flow
$1.3B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Free Cash Flow
$4.3B
CAGR 3-Years
28%
CAGR 5-Years
9%
CAGR 10-Years
20%
Abbott Laboratories
NYSE:ABT
Free Cash Flow
$7.4B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
15%
Intuitive Surgical Inc
NASDAQ:ISRG
Free Cash Flow
$2.5B
CAGR 3-Years
37%
CAGR 5-Years
17%
CAGR 10-Years
13%
No Stocks Found

Teleflex Inc
Glance View

In the world of medical technology, Teleflex Inc. emerges as a nuanced, multifaceted player, crafting a narrative not just of survival, but of steady growth through innovation and strategic vision. Founded in the allure of post-war optimism in 1943, Teleflex began its journey in the aerospace and marine industries. However, recognizing the steadily aging global population and increasing healthcare demands, the company pivoted towards the medical sector, a decision that has since defined its contemporary identity. Teleflex now thrives as a diversified global provider of medical technologies designed to improve health and the quality of people's lives. It specializes in critical care and surgical solutions, focusing its efforts on areas like vascular access, anesthesia, respiratory care, and urology, among others. Teleflex Inc. crafts its financial landscape through a robust combination of product innovation, strategic acquisitions, and a strong global footprint. Their revenue streams are primarily derived from selling medical devices and equipment to healthcare providers worldwide. A significant competitive edge lies in its ability to consistently introduce new products that address unmet clinical needs while enhancing patient safety and outcomes. This focus is evident in their Research and Development initiatives, which are integral to maintaining their market position. Moreover, by acquiring companies with complementary technologies and market reach, Teleflex continually broadens its portfolio, navigating the complex and evolving healthcare landscape with finesse and agility. Through these strategic maneuvers, the company ensures a steady flow of revenue that aligns with global healthcare trends and demands.

TFX Intrinsic Value
126.55 USD
Overvaluation 7%
Intrinsic Value
Price $136.56

See Also

What is Teleflex Inc's Free Cash Flow?
Free Cash Flow
245.4m USD

Based on the financial report for Dec 31, 2025, Teleflex Inc's Free Cash Flow amounts to 245.4m USD.

What is Teleflex Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
0%

Over the last year, the Free Cash Flow growth was -55%. The average annual Free Cash Flow growth rates for Teleflex Inc have been -2% over the past three years , -7% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett